Celon Pharma S.A. | CLN Logo | Annual Report & Investor Relations Data

Celon Pharma S.A. | CLN Annual Report & Investor Relations Data

ISIN

PLCLNPH00015

Ticker

CLN

Sector

Health Care

Industry

Pharmaceuticals

Country

Poland

Year Founded

2002

Celon Pharma S.A. (CLN)
Company Overview & Profile

Company Description

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for it products. The drugs we offer help thousands of patients lead a better and longer life.

One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs. The research and development department in Celon Pharma S.A.employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy or chemistry.

We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes and other metabolic disorders. We have obtained financial resources for research into new drugs from the sale of generic drugs, as well as from the EU funds obtained under the Innovative Economy programme.

Served Area

Worldwide

Headquarters

Marymoncka 15
05-152, Kazuń Nowy
Poland

Celon Pharma S.A. (CLN)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Celon Pharma S.A. (CLN)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Celon Pharma S.A. (CLN)
Stock & Investor Information

ISIN

PLCLNPH00015

LEI

259400Q0ERJT0NC5DT24

Stock Exchange Listings

Warsaw Stock Exchange

Industry Classification

Celon Pharma S.A. (CLN)
Related Companies & Peer Group

ABIVAX Logo

ABIVAX

ABVX

Sector

Health Care

Country

France

ISIN

FR0012333284

Founded

Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …

Addex Therapeutics Ltd Logo

Addex Therapeutics Ltd

ADXN

Sector

Health Care

Country

Switzerland

ISIN

CH0029850754

Founded

2002

Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …

AegirBio AB Logo

AegirBio AB

AEGIR

Sector

Health Care

Country

Sweden

ISIN

SE0014401121

Founded

2019

AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …

Alkaloid AD Logo

Alkaloid AD

None

Sector

Health Care

Country

North Macedonia

ISIN

MKALKA101011

Founded

1936

Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …

Antibiotice S.A. Logo

Antibiotice S.A.

ATB

Sector

Health Care

Country

Romania

ISIN

ROATBIACNOR9

Founded

1955

The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …

AstraZeneca PLC Logo

AstraZeneca PLC

AZN

Sector

Health Care

Country

United Kingdom

ISIN

GB0009895292

Founded

1999

We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …